<DOC>
	<DOC>NCT00904085</DOC>
	<brief_summary>The purpose of this study was to compare the analgesic efficacy of 5 mg oxymorphone IR with placebo in patients with mild to moderate pain following outpatient knee arthroscopy.</brief_summary>
	<brief_title>Post-operative Efficacy and Safety Study</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Oxymorphone</mesh_term>
	<criteria>Males or females, 18 years of age or older, who have completed outpatient knee arthroscopy Have an initial pain intensity score of between 30mm and 70mm on a 100mm Visual Analogue Scale(VAS) and a categorical pain rating scale of none, mild, moderate, or severe, Have been informed of the nature of the study and provided written informed consent Have a positive pregnancy test Have received any of the following medications within 24 hours prior to dosing: COX2 inhibitors, Minor Tranquilizers, Muscle relaxants, Antihistamines Longacting oral and parenteral analgesics are prohibited for at least 12 hours prior to receiving study medication. Have received any of the following medication within 48 hours prior to dosing: Chronic use of analgesics (opioid or nonopioid including aspirin [&gt;325 mg/day], acetaminophen, and NSAIDs) Have received MAOI drugs within 2 weeks prior to dosing Not stabilized on the following medications for at least 4 weeks prior to dosing: Tricyclic antidepressant drugs, Serotonin reuptake inhibitors, Amphetamines used for ADHD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>